Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 21, 2020; 26(31): 4703-4717
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4703
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4703
Figure 6 The prognostic value of model for end-stage liver disease score, mucosal-associated invariant T cell counts and percentage of mucosal-associated invariant T cells in patients with hepatitis B virus-related liver failure.
The receiver characteristic operator curve of model for end-stage liver disease (MELD) score and mucosal-associated invariant T (MALT) cells counts and percentage (%). AUC: Area under the curve.
- Citation: Xue H, Li H, Ju LL, Han XD, Cheng TC, Luo X, Chen L, Shao JG, She YJ, Bian ZL. Mucosal-associated invariant T cells in hepatitis B virus-related liver failure. World J Gastroenterol 2020; 26(31): 4703-4717
- URL: https://www.wjgnet.com/1007-9327/full/v26/i31/4703.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i31.4703